Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

GCA and polymyalgia rheumatica are on opposite ends of the spectrum of the same disease. Temporal artery biopsy is the gold standard for the diagnosis of GCA. Polymyalgia rheumatica should be ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

Fibromyalgia is a disorder that causes widespread ... but it tends to be limited to affected joints. Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes muscle pain and stiffness.

Many different conditions can cause similar symptoms to rheumatoid arthritis, including fibromyalgia, SLE, psoriatic arthritis. There is also an overlap of symptoms between RA and these conditions, ...

Diagnosing fibromyalgia (FM) can be challenging. It's not uncommon for someone to ask their healthcare provider if they could have the condition only to have the suggestion waved off. What's going on?

Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...

There has been little basis on which to standardise a diagnosis of polymyalgia rheumatica (PMR), and so 11 rheumatology units in the south and west of Great Britain have collaborated in a study to ...

This development could mark the introduction of the first new drug for fibromyalgia in over 15 years, addressing the needs of more than 10 million adults in the U.S. affected by this chronic pain ...

Alongside arthritis, other common health issues include osteoarthritis, back pain, rheumatoid arthritis, fibromyalgia, osteoporosis, gout, polymyalgia rheumatica, lupus, and ankylosing spondylitis. If ...

TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA ...